February 20, 2017 6:59 AM ET

Life Sciences Tools and Services

Company Overview of Catalent Pharma Solutions, Inc.

Company Overview

Catalent Pharma Solutions, Inc. provides development solutions and delivery technologies for drugs, biologics, and consumer health products. The company’s Development and Clinical Services segment offers manufacturing, packaging, storage, and inventory management services for drugs and biologics in clinical trials. This segment also provides analytical chemical and cell-based testing and scientific services; respiratory products formulation and manufacturing; regulatory consulting; and bioanalytical testing for biologic products. Its Oral Technologies segment offers oral delivery technologies, including formulation, development, and manufacturing services for the oral dose forms comprising p...

14 Schoolhouse Road

Somerset, NJ 08873

United States

8,300 Employees

Phone:

732-537-6200

Fax:

732-537-6480

Key Executives for Catalent Pharma Solutions, Inc.

Chief Executive Officer, President and Director
Age: 52
Chief Financial Officer, Principal Accounting Officer and Executive Vice President
Age: 49
Senior Vice President of Global Operations
Age: 54
President of Advanced Delivery Technologies
Age: 50
President of Catalent Asia Pacific
Compensation as of Fiscal Year 2016.

Catalent Pharma Solutions, Inc. Key Developments

Catalent Pharma Solutions, Inc. Presents at 35th Annual JP Morgan Healthcare Conference, Jan-09-2017 09:30 AM

Catalent Pharma Solutions, Inc. Presents at 35th Annual JP Morgan Healthcare Conference, Jan-09-2017 09:30 AM. Venue: Westin St. Francis Hotel, 335 Powell Street, San Francisco, CA 94102, United States.

Catalent Pharma Solutions, Inc. Presents at 9th Annual Conference Biotech Showcase, Jan-09-2017

Catalent Pharma Solutions, Inc. Presents at 9th Annual Conference Biotech Showcase, Jan-09-2017 . Venue: HILTON SAN FRANCISCO UNION SQUARE, 333 O'Farrell Street, San Francisco, CA 94102, United States.

Catalent Completes Repricing of Credit Agreement

Catalent announced that Catalent Pharma Solutions has completed an amendment to its senior secured credit facilities to lower the interest rate on its U.S. dollar-denominated and euro-denominated term loans. The new applicable rate for U.S. dollar-denominated term loans is LIBOR plus 2.75%, which is 0.50% lower than the previous rate, and the new applicable rate for euro-denominated term loans is LIBOR plus 2.50%, which is 0.75% lower than the previous rate. The amendment also includes a prepayment premium of 1.0% in the event of another repricing event on or before the six-month anniversary of the amendment. There is no change to maturities or covenants as a result of this repricing amendment.

Similar Private Companies By Industry

Company Name Region
10X Genomics, Inc. United States
4G Clinical, Inc. United States
AAPharmaSyn LLC United States
Abiant, Inc. United States
aBioBot, Inc. United States

Recent Private Companies Transactions

Type
Date
Target
Merger/Acquisition
November 28, 2016
Accucaps Industries Limited
Merger/Acquisition
September 13, 2016
Pharmatek Laboratories, Inc.
Bankruptcy
April 30, 2016
NephroGenex, Inc.
 

The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Lawyers Committee for Civil Rights Under Law United States
NYC2012, Inc. United States
Bertelsmann AG Europe
Rush University United States
Bloomberg L.P. United States

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact Catalent Pharma Solutions, Inc., please visit www.catalent.com. Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.